Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays a new revision tag (Revision: v3.5.4), indicating an administrative update to the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:50:28.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The 'Last known status' section, including the investigator's name and affiliation and the verification line, was removed from the study record. This changes what provenance details are visible on the page, affecting traceability of the study's status history.
    Difference
    0.4%
    Check dated 2026-05-11T01:44:32.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s display revision/version label was updated from v3.5.2 to v3.5.3, indicating a site software update without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:23:51.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Results have been submitted, replacing the previous 'No Results Posted' status. The page revision has been updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:37:53.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; no changes to the study details or core functionality are observed.
    Difference
    0.1%
    Check dated 2026-03-21T19:55:53.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T06:13:22.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.